In a recent Relentless Health Value podcast, Accreditation Council for Medical Affairs President and CEO William Soliman discussed how trained and certified medical affairs teams could benefit pharmaceutical companies. Soliman, according to Relentless Health Value, has held "key positions" in which […]
Majority of Americans Back Drug Prices in DTC Ads, Survey Finds
A recent survey from the Kaiser Family Foundation found three-quarters of Americans support the idea of including drug prices in direct-to-consumer advertisements. The survey, according to an MM&M report, reported 83 percent of Democrats, 73 percent of independents and 72 percent of Republicans […]
ICER Advisory Group to Guide Report on Drug Price Increases Not Backed by Clinical Evidence
The Institute of Clinical and Economic Review (ICER) on Wednesday announced the creation of a new advisory group to play a key role in a new report focused on unsupported drug price increases. ICER says it plans to issue its report during the first quarter of 2019. "The federal government has […]
AMCP Learn Offers Best of Annual 2018 Nexus Meeting
The Academy of Managed Care Pharmacy is offering ten top-rated sessions of its 2018 Nexus meeting on AMCP Learn. The offering is available until April 25, 2021, according to AMCP's website. AMCP is offering in the set home study activities, including:AMCP Headline Session: 2017–2018 […]
Eyeforpharma Webinar to Spotlight Blockchain
Eyeforpharma is offering a free June 27 webinar which aims to analyze the ways in which blockchain technology can better build trust and transparency in the pharmaceutical industry. The web event is slated to kick off at 10 a.m. EST. "We'll explore how new technology and contract innovation offers […]
A Look at Drugmaker Transactions, Partnerships so Far this Year
A recent report on Beckers Hospital Review offers a look at 20 drugmaker transactions and partnerships which the outlet has covered so far in 2018, including the $2.4 billion acquisition of Foundation Medicine by Roche. " ... Experts from some of the largest drug manufacturers are expecting the […]
Will Competition Really Drive Down Prices?
President Donald Trump's administration appears to have hopes that pushing the drug market to control pharmaceutical prices will help drive down costs naturally, but Elisabeth Rosenthal in a New York Times column says, with history as a reference point, that's unlikely. "Competition may work well […]
Outcomes-Based Contracts: Much hype, Far Less Practice?
While outcomes-based contracts have been a hot buzzword for some time, little has been done on a broad scale to implement the alternative payment strategy, eyeforpharma reports. Value-based pricing models in the U.S. have been mostly "few and far between," according to the report, there are several […]
Axios: Patients Caught in Drug Pricing War
Axios in a video published Thursday says patients are caught in the middle of a "drug pricing war" which has left patients in the middle of the battleground. Click here to watch the video report on Axios. […]
NPC’s Webinar ‘Barriers to Paying for Value’ Nears
Hurry and secure your spot for the National Pharmaceutical Council's June 26 webinar, "Barriers to Paying for Value." The webinar, which is set to begin at noon EST, will focus on the council's recent paper, "Regulatory Barriers Impair Alignment of Biopharmaceutical Price and Value," which […]
